Journal
CELL
Volume 184, Issue 4, Pages 881-898Publisher
CELL PRESS
DOI: 10.1016/j.cell.2021.01.017
Keywords
-
Categories
Funding
- American Gastroenterological Association Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease
- NIH [5F31HL149334, 1R56EB027729-01A1, 1R01GM129011-01, R01EB029483, 1DP2CA186574]
- Paul G. Allen Frontiers Group
- Wyss Institute
- Boston University Ignition Award
- NSF [1522074]
- NSF CAREER [162457]
- NSF BBSRC [1614642]
Ask authors/readers for more resources
Synthetic biology is a design-driven discipline focused on engineering novel biological functions through the discovery and repurposing of molecular parts. Applications in vaccine development, molecular diagnostics, and cell-based therapeutics are already in clinical use or active clinical trials, with ongoing innovations likely to have a significant impact on future biomedicine applications.
Synthetic biology is a design-driven discipline centered on engineering novel biological functions through the discovery, characterization, and repurposing of molecular parts. Several synthetic biological solutions to critical biomedical problems are on the verge of widespread adoption and demonstrate the burgeoning maturation of the field. Here, we highlight applications of synthetic biology in vaccine development, molecular diagnostics, and cell-based therapeutics, emphasizing technologies approved for clinical use or in active clinical trials. We conclude by drawing attention to recent innovations in synthetic biology that are likely to have a significant impact on future applications in biomedicine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available